Company Overview of f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H., a biopharmaceutical company, designs, develops, and manufactures novel bispecific monoclonal antibodies for the treatment of serious diseases with a focus on immuno-oncology and inflammatory diseases. It offers Modular Antibody Technology, a proprietary engine that generates bispecific antibodies; Fcab, which offers a fundamentally new binding region within an antibody; mAb2 bispecific monoclonal antibodies; and IP portfolio, including patents, trademarks, and trade secrets. The company was founded in 2006 and is headquartered in Vienna, Austria. It has a research site in Cambridge, the United Kingdom.
Founded in 2006
43 72055 4215
43 865 55 56
Key Executives for f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Key Developments
Similar Private Companies By Industry
|Activartis Biotech GmbH||Europe|
|APEIRON Biologics AG||Europe|
|Apeptico Forschung und Entwicklung GmbH||Europe|
|ARTMA Medical Technologies AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H., please visit www.f-star.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.